Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Semin Arthritis Rheum. 2011 Jun;40(6):512-531.e8. doi: 10.1016/j.semarthrit.2010.07.009. Epub 2010 Nov 2.
We evaluated the epidemiologic evidence that vitamin D may be related to human autoimmune disease risk.
PubMed, limited to English from inception through April 2010, was searched using keywords: "vitamin D," "autoimmune," and autoimmune disease names. We summarized in vitro, animal, and genetic association studies of vitamin D in autoimmune disease pathogenesis. We sorted epidemiologic studies by design and disease and performed a systematic review of (a) cross-sectional data concerning vitamin D level and autoimmune disease; (b) interventional data on vitamin D supplementation in autoimmune diseases; and (c) prospective data linking vitamin D level or intake to autoimmune disease risk.
Vitamin D has effects on innate and acquired immune systems, and vitamin D receptor polymorphisms have been associated with various autoimmune diseases. In experimental animal models, vitamin D supplementation can prevent or forestall autoimmune disease. Of 1446 studies identified and screened, 76 studies examined vitamin D levels in autoimmune disease patients, particularly with active disease, and compared with controls. Nineteen observational or interventional studies assessed the effect of vitamin D supplementation as therapy for various autoimmune diseases (excluding psoriasis and vitiligo) with a range of study approaches and results. The few prospective human studies performed conflict as to whether vitamin D level or intake is associated with autoimmune disease risk. No interventional trials have investigated whether vitamin D affects human autoimmune disease risk.
Cross-sectional data point to a potential role of vitamin D in autoimmune disease prevention, but prospective interventional evidence in humans is still lacking.
我们评估了维生素 D 可能与人类自身免疫性疾病风险相关的流行病学证据。
通过使用关键词“vitamin D”、“autoimmune”和自身免疫性疾病名称,对截至 2010 年 4 月的 PubMed 进行了限制为英语的检索。我们总结了维生素 D 在自身免疫性疾病发病机制中的体外、动物和遗传关联研究。我们按设计和疾病对流行病学研究进行了分类,并对(a)关于维生素 D 水平与自身免疫性疾病的横断面数据;(b)自身免疫性疾病中维生素 D 补充的干预数据;以及(c)将维生素 D 水平或摄入量与自身免疫性疾病风险联系起来的前瞻性数据进行了系统评价。
维生素 D 对先天和获得性免疫系统有影响,维生素 D 受体多态性与各种自身免疫性疾病有关。在实验动物模型中,维生素 D 补充可以预防或阻止自身免疫性疾病的发生。在确定和筛选的 1446 项研究中,有 76 项研究检查了自身免疫性疾病患者(尤其是活动期患者)的维生素 D 水平,并与对照组进行了比较。有 19 项观察性或干预性研究评估了维生素 D 补充作为治疗各种自身免疫性疾病(不包括银屑病和白癜风)的疗效,采用了不同的研究方法和结果。为数不多的前瞻性人类研究在维生素 D 水平或摄入量与自身免疫性疾病风险之间的关系上存在争议。没有干预性试验研究过维生素 D 是否会影响人类自身免疫性疾病的风险。
横断面数据表明维生素 D 可能在预防自身免疫性疾病方面发挥作用,但在人类中仍然缺乏前瞻性的干预证据。